Your search for "app" return 7 results.
Coglapix® - Economic benefit study versus an antibiotic in the control of A.P. >
The Vaccine group (with Coglapix®) and Antibiotic group have the higher performance and more profit than the Control group. Although the similar performance, the economic impact given by the Vaccine g...
APP: Comparison Of Four Different Vaccines Under Field Conditions In The Philippines >
A trial under field conditions has been conducted in the Philippines in comparison Coglapix® with two toxoid vaccines and one bacterin vaccine of the market. In this trial, Coglapix®, the toxoid vacci...
Coglapix® and the procedure to control pleuro-pneumonia caused by Actinobacillus pleuropneumoniae (APP) >
In the recent years, the pig farms in the whole world always control APP following a strict process including diagnosis, prevention, treatment and regular monitoring together with good farm practices...
Porcine Pleuropneumonia - Good Protection Without Stress: COGLAPIX® >
The protection of a farm against APP may combine different solutions including husbandry management measures concerning the control of the introduced animals, reasoned antibiotic use for short treatme...
Porcine Pleuropneumonia: From A Good Detection To A Good Protection >
In this new issue of Axis, we would like to have anupdate on the swine pleuro-pneumonia, the management of the disease and the prevention possibilities. Ceva Santé Animale has developed a new vaccine,...
Pleuropneumonia in pigs - its importance and prevention >
Porcine Pleuropneumonia is a major threat in pig farms. The prevalence is high and the economic consequences are serious, because of mortality, and the decrease on performances. The pathogenesis of th...
Vaccines >
Ceva is committed to swine vaccines with its Research and Development sites located in different continents worldwide investing substantial resources in innovation and production.